CeLac and European consortium for a personalized medicine approach to Gastric Cancer
Datos básicos
- Protocolo:
- 825832
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- 2019
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
EUROPEAN COMMISSION
Resultados del Ensayo Clínico
In the literature: October 2020.
Gambardella, Valentina; (...); Cervantes, Andres
Article. 10.1136/esmoopen-2020-001048. 2020
Quadruple therapies show a higher eradication rate compared to standard triple therapy for Helicobacter pylori infection within the LEGACy consortium. A multicenter observational study in European and Latin American countries.
Medel-Jara, P; (...); Riquelme, A
Article. 10.1002/ueg2.12605. 2024